Ceska a Slovenska Farmacie, volume 71, issue 5, pages 63-69
Selektívne inhibítory cyklooxygenázy 2 – ich minulosť, prítomnosť a budúcnosť
Valášková S., Kyselovič J., Gažová A.
Publication type: Journal Article
Publication date: 2022-01-01
Journal:
Ceska a Slovenska Farmacie
scimago Q3
SJR: 0.162
CiteScore: 0.9
Impact factor: —
ISSN: 12107816, 18054439
Pharmaceutical Science
Abstract
Pain is a serious subjective experience, which, although it has a protective nature, it physically and mentally exhausts the patient. The pharmacological field of development and research in the treatment and relief of pain has been dynamic and interesting ever since the isolation of salicylic acid. After discovering the molecular nature of cyclooxygenase and its inhibition, research focused on selective COX-2 inhibitors, but they were a big disappointment. Today, the possibility of contributing to safe and effective analgesic-antiphlogistic treatment for the patient with a combination of drugs is emerging again
Found
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.